Skip to content

Pharmac funds cancer drug for some — but this father faces $17,000 a month

A Christchurch father battling stage 4 bowel cancer faces a $17,000 monthly bill for a drug already funded by Pharmac for some breast cancer patients.

Summarised by Centrist

A Christchurch father battling stage 4 bowel cancer faces a $17,000 monthly bill for a drug already funded by Pharmac for some breast cancer patients.

Mike Hrynkewycz, 46, has cancer that has spread to his brain and lungs. His family has spent nearly $100,000 on treatment since his diagnosis in September 2025.

The drug, Enhertu, targets cancers carrying the HER2 protein. Medsafe approved its use for Mike's cancer type in September, but Pharmac has not extended public funding to bowel cancer patients.

Each infusion costs more than $12,000, with treatment required every three weeks.

Medsafe's approval unlocked $10,000 in annual support from Southern Cross, leaving the family to cover most of the cost themselves.

A previous application for a different treatment was rejected after Pharmac concluded Mike's circumstances were not sufficiently exceptional. Clinical advice suggested 60 to 80 New Zealand patients could have similar needs.

Pharmac says it had not received a formal funding application for Enhertu to treat HER2-positive bowel cancer as of 19 October, but would welcome one.

Mike's wife Harriet works part-time while caring for him and their two children. The family estimates it can afford another six rounds of treatment.

The case highlights the distinction between Medsafe approving a medicine for use and Pharmac agreeing to fund it.

Read more at The NZ Herald

Re-published from the Centrist with permission

Original article at The Centrist

Latest

Quick Hit

Quick Hit: The RNZ CFO Timeline

RNZ’s finance chief raised ‘differences’ in the accounts on 2 October and resigned at 8.46pm. A board member was offered the job the next morning. The minister was told on Monday. The emails are still withheld.

Members Public
An Unelected Opposition

An Unelected Opposition

A survey of 718 public servants found 55 per cent would brief the media to make a minister’s policy politically untenable. The next coalition agreement needs a clause for the public service, not just the ministers.

Members Public